Issues of solvation in drug design.

被引：0

作者：

Stouch, TR ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Comp Assisted Drug Design, Princeton, NJ 08543 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2002年 / 224卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

031-COMP

引用

页码：U474 / U474

页数：1

共 50 条

[1] Solvation modeling for rational drug design.
Truhlar, DG
Cramer, CJ
Thompson, JD
Winget, PD
Xidos, JD
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : U464 - U465
[2] Chirality and drug design.
Anderson, PS
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 285 - MEDI
[3] Intelligent design. Philosophical and societal issues
Feltz, Bernard
[J]. REVUE PHILOSOPHIQUE DE LOUVAIN, 2009, 107 (03) : 387 - 409
[4] The latentiation process in drug design.
Chin, CM
Ferreira, EI
[J]. QUIMICA NOVA, 1999, 22 (01): : 75 - 84
[5] Molecular connectivity and drug design.
Galvez, J
Garcia-Domenech, R
de Julián-Ortiz, JV
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U284 - U284
[6] The importance of metabolism in drug design.
Pereira, Darcio Gomes
[J]. QUIMICA NOVA, 2007, 30 (01): : 171 - 177
[7] Bioavailability consideration in drug design.
Baldwin, JJ
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U459 - U459
[8] WEAK KNOWLEDGE. ISSUES ON TECHNOLOGICAL DESIGN.
Parselis, Martin
[J]. SOCIOLOGIA Y TECNOCIENCIA, 2015, 1 (05): : 1 - 9
[9] Computer-aided drug design.
Holloway, MK
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U544 - U544
[10] Use of genomic information in drug design.
Caron, P
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U390 - U390